by James Odell, OMD, ND, L.Ac.
A Swedish study published in January this year found that the messenger ribonucleic acid (mRNA) in Pfizer’s shot was able to alter DNA in liver cells.1 This alteration, known as reverse transcription, is when mRNA writes to DNA and is the opposite of the normal transcription process. Normally, it is a portion of the DNA that is transcribed into an mRNA molecule, which then forms the specified protein.
News agencies and so-called fact-checkers played down the significance of this Swedish,University of Lund, research so as not to disrupt the mass genetic inoculation programs still underway across the world. These pharmaceutical-sponsored fact-checkers countered this groundbreaking research that because this was an in vitro study - liver cancer cells growing in the laboratory - the “findings cannot be extrapolated to people”. This concerning, if not outright terrifying, study’s findings were completely ignored, and in the light of science, should have signaled a stop to the mass experimental inoculations, at least until further studies can be performed. The potential of changing human DNA with a drug is hugely paramount to the future of humankind and should never be ignored or casually dismissed.
In May of this year, another team of scientists, led by stem cell biologist Rudolf Jaenisch and gene regulation specialist Richard Young of the Massachusetts Institute of Technology published a paper titled, Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. In their original preprint, the researchers presented in vitro evidence that when human cells spiked with extra LINE-1 elements were infected with the coronavirus, DNA versions of SARS-CoV-2's sequences entered the cells' chromosomes.
They wrote: “We investigated the possibility that SARS-CoV-2 RNAs can be reverse-transcribed and integrated into the DNA of human cells in culture, and that transcription of the integrated sequences might account for some of the positive PCR tests seen in patients. In support of this hypothesis, we found that DNA copies of SARS-CoV-2 sequences can be integrated into the genome of infected human cells. “We show here that SARS-CoV-2 RNA can be reverse-transcribed and integrated into the genome of the infected cell and be expressed as chimeric transcripts fusing viral with cellular sequences. Importantly, such chimeric transcripts are detected in patient-derived tissues. Our data suggest that, in some patient tissues, the majority of all viral transcripts are derived from integrated sequences.”2
This latest study received no press from mainstream media either and is also being ignored by the largely pharmaceutical-bought and paid-for scientific community. Critics still question whether the cell culture data have relevance to human health or diagnostics. It is important to know that evidence exists that in-vitro studies are capable or potentially capable of providing more rapid, precise, and relevant information than some animal studies. Currently, the primary use of in-vitro tests is the detection of specific toxic properties of drugs and chemicals, (e.g., mutagenesis and mechanisms of toxicity.) The theoretical basis for this stems from the commonality of the basic structure and behavior of genetic material whereby in-vitro tests for genetic toxicology can replace animal tests. Thus, the in vitro method historically is said to give equal or sometimes more accurate results than animal tests.
So, are not the criticisms of these two in vitro studies more founded on politics and finance than science? Scary to think it will still take more time and studies to validate this reverse transcription process, while in the meantime, people throughout the world continue to be inoculated with this experimental jab that possibly can detrimentally alter our DNA.
Aldén, Markus, Francisko Olofsson Falla, Daowei Yang, Mohammad Barghouth, Cheng Luan, Magnus Rasmussen, and Yang De Marinis. "Intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 in vitro in human liver cell line." Current issues in molecular biology 44, no. 3 (2022): 1115-1126.
Zhang, Liguo, Alexsia Richards, M. Inmaculada Barrasa, Stephen H. Hughes, Richard A. Young, and Rudolf Jaenisch. "." Proceedings of the National Academy of Sciences 118, no. 21 (2021): e2105968118.